Original filing text · Part II

Item 1 — Legal Proceedings

Ionis Pharmaceuticals, Inc. · 10-Q · Q2 FY2026 · Period ended Jun 30, 2026

This is the extracted source text from the SEC filing. Formatting may differ from the original document.

For details of legal proceedings, refer to Part I, Item 1, Note 12, Legal Proceedings, in the Notes to Condensed Consolidated Financial Statements.